# TK-based Suicide Gene Therapy for Hepatocellular Carcinoma

> **NCT00844623** · PHASE1 · COMPLETED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 10 (actual)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **GENETIC:** TK99UN

## Key facts

- **NCT ID:** NCT00844623
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2003-11
- **Final completion:** 2008-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00844623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00844623, "TK-based Suicide Gene Therapy for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00844623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*